Network pharmacology integrates systems biology and bioinformatics to explore the intricate relationships among drugs, targets, diseases, and other molecular docking used to explore the effect of Musa acuminata against obsessive-compulsive disorder (OCD). OCD is a behavioral and mental neurological condition. The occurrence of patients with OCD has increased in recent times due to both genetic and environmental factors. Genetic factors involve variations in certain genes that give instructions for proteins that react to or transport the neurotransmitter known as serotonin which has been associated with an increased risk of OCD. Thus, the present study aims to establish the therapeutic properties of M. acuminata, that is, banana against environment-induced OCD. The active components of M. acuminata were screened through IMPPAT 2.0, NPASS, and HMDB databases. Corresponding gene targets of active ingredients were found by using STITCH and comparative toxicogenomics database databases. Similarly, the genes involved in OCD were screened with the help of the Gene Cards and DisGeNET database. Utilizing the Gene Cards and DisGeNET database, 2,966 gene targets of OCD were obtained. The network interaction map of gene targets was created using STRING and the CytoHubba plugin of Cytoscape, and the top interacting targets were then filtered away. Finally, the prophylactic activity of active ingredients of M. acuminata against OCD was studied through a molecular docking strategy. This research utilized a network pharmacology-integrated molecular docking approach to study the therapeutic properties of M. acuminata against OCD.
Ansari H, Garg P, Rashmi KS, Bernhardt GV, Srivastava P. Network pharmacology and molecular docking reveals the therapeutic mechanism of Musa acuminata against obsessive-compulsive disorder. J Appl Pharm Sci. 2024. Online First. http://doi.org/10.7324/JAPS.2024.154791
1. Burger A. Approaches to drug discovery. N Engl J Med. 1964;270:1098–101. doi: https://doi.org/10.1056/NEJM196405212702106
2. Janardhan Reddy YC, Rao NP, Khanna S. An overview of Indian research in obsessive compulsive disorder. Indian J Psych. 2010;52:200–9.
3. Fenske JN, Petersen K. Obsessive-compulsive disorder: diagnosis and management. Am Fam Phys. 2015:896–903.
4. Robbins TW, Vaghi MM, Banca P. Obsessive-compulsive disorder: puzzles and prospects. Neuron. 2019;102(1):27–47. doi: https://doi.org/10.1016/j.neuron.2019.01.046
5. Krebs G, Heyman I. Obsessive-compulsive disorder in children and adolescents. Arch Dis Child. 2015;100(5):495–9. doi: https://doi.org/10.1136/archdischild-2014-306934
6. Fenske JN, Schwenk TL. Obsessive compulsive disorder: diagnosis and management. Am Fam Phys. 2009:239–45.
7. Mathew NS, Negi PS. Traditional uses, phytochemistry and pharmacology of wild banana (Musa acuminata Colla). J Ethnopharmacol. 2017;196:124–40.
8. Pereira A, Maraschin M. Banana (Musa spp) from peel to pulp: ethnopharmacology, source of bioactive compounds and its relevance for human health. J Ethnopharmacol. 2015;160:149–63. doi: https://doi.org/10.1016/j.jep.2014.11.008
9. Oyeyinka BO, Afolayan AJ. Suitability of banana and plantain fruits in modulating neurodegenerative diseases: implicating the in vitro and in vivo evidence from neuroactive narratives of constituent biomolecules. Foods. 2022;11(15):2263. doi: https://doi.org/10.3390/foods11152263
10. Samad N, Muneer A, Ullah N, Zaman A, Ayaz MM, Ahmad I. Banana fruit pulp and peel involved in antianxiety and antidepressant effects while invigorate memory performance in male mice: possible role of potential antioxidants. Pak J Pharm Sci. 2017 May;30(3(Suppl.):989–95.
11. Hopkins AL. Network pharmacology. Nat Biotechnol. 2007;25(10):1110–1. doi: https://doi.org/10.1038/nbt1007-1110
12. Jiang Y, Zhong M, Long F, Yang R, Zhang Y, Liu T. Network pharmacology-based prediction of active ingredients and mechanisms of Lamiophlomis rotata (Benth.) Kudo against rheumatoid arthritis. Ethnopharmacology. 2019;10:1435.
13. Mohanraj K, Karthikeyan BS, Vivek-Ananth RP, Chand RPB, Aparna SR, Mangalapandi P, et al. IMPPAT: a curated database of Indian medicinal plants, phytochemistry and therapeutics. Sci Rep. 2018;8(1):4329. doi: https://doi.org/10.1038/s41598-018-22631-z
14. Zeng X, Zhang P, He W, Qin C, Chen S, Tao L, et al. NPASS: natural product activity and species source database for natural product research, discovery and tool development. Nucleic Acids Res. 2018;46:1217–22.
15. Wishart DS, Tzur D, Knox C, Eisner R, Guo AC, Young N, et al. HMDB: the human metabolome database. Nucleic Acids Res. 2007;35:521–6.
16. Kuhn M, von Mering C, Campillos M, Jensen LJ, Bork P. STITCH: interaction networks of chemicals and proteins. Nucleic Acids Res. 2008;36:684–8.
17. Davis AP, Grondin CJ, Johnson RJ, Sciaky D, Wiegers J, Wiegers TC, et al. Comparative toxicogenomics database (CTD). Nucleic Acids Res. 2020;49:D1138–43.
18. Piñero J, Bravo À, Queralt-Rosinach N, Gutiérrez-Sacristán A, Deu-Pons J, Centeno E, et al. DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants. Nucleic Acids Res. 2017;45:833–9.
19. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498–504. doi: https://doi.org/10.1101/gr.1239303
20. Kim S. PubChem Substance and Compound databases. Nucleic Acids Res. 2016;44:1202–13.
21. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, et al. The protein data bank. Nucleic Acids Res. 2000;28(1):235–42. doi: https://doi.org/10.1093/nar/28.1.235
22. Samad N, Muneer A, Ullah N, Zaman A, Ayaz MM, Ahmad I. Banana fruit pulp and peel involved in antianxiety and antidepressant effects while invigorate memory performance in male mice: possible role of potential antioxidants. Pak J Pharm Sci. 2017 May;30(3(Suppl.):989–95.
23. Og?odek EA, Szota AM, Just MJ, Mo? DM, Araszkiewicz A. The MCP-1, CCL-5 and SDF-1 chemokines as pro-inflammatory markers in generalized anxiety disorder and personality disorders. Pharmacol Rep. 2015 Feb;67(1):85–9.
24. Fontenelle LF, Barbosa IG, Luna JV, de Sousa LP, Abreu MN, Teixeira AL. A cytokine study of adult patients with obsessive-compulsive disorder. Compr Psychiatry. 2012;53(6):797–804. doi: https://doi.org/10.1016/j.comppsych.2011.12.007
25. Rao NP, Venkatasubramanian G, Ravi V, Kalmady S, Cherian A, Yc JR. Plasma cytokine abnormalities in drug-naïve, comorbidity-free obsessive-compulsive disorder. Psychiatry Res. 2015;229:949–52.
26. Hanna GL, Veenstra-VanderWeele J, Cox NJ, Boehnke M, Himle JA, Curtis GC, et al. Genome-wide linkage analysis of families with obsessive-compulsive disorder ascertained through pediatric probands. Am J Med Genet. 2002;114(5):541–52. doi: https://doi.org/10.1002/ajmg.10519
27. O’Malley WE, Achinstein B, Shear MJ. Action of bacterial polysaccharide on tumors. II. Damage of sarcoma 37 by serum of mice treated with Serratia marcescens polysaccharide, and induced tolerance. Nutr Rev. 1998;46:389–91.
28. Zhang BB, Liu XZ, Sun J, Yin YW, Sun QQ. Association between TNF α gene polymorphisms and the risk of duodenal ulcer: a meta-analysis. PLoS One. 2013;8(2):e57167. doi: https://doi.org/10.1371/journal.pone.0057167
29. EI-El-Tahan RR, Ghoneim AM, El-Mashad N. TNF-α gene polymorphisms and expression. Springerplus. 2016;5(1):1508. doi: https://doi.org/10.1186/s40064-016-3197-y
30. Kronfol Z, Remick DG. Cytokines and the brain: implications for clinical psychiatry. Am J Psychiatry. 2000;157(5):683–94. doi: https://doi.org/10.1176/appi.ajp.157.5.683
31. Cappi C, Muniz RK, Sampaio AS, Cordeiro Q, Brentani H, Palácios SA, et al. Association study between functional polymorphisms in the TNF-alpha gene and obsessive-compulsive disorder. Arq Neuro Psiquiatr. 2012;70(2):87–90. doi: https://doi.org/10.1590/s0004-282x2012000200003
32. Zhu S, Liu F, Zhang R, Xiong Z, Zhang Q, Hao L, et al. Neuroprotective potency of neolignans in Magnolia officinalis cortex against brain disorders. Front Pharmacol. 2022;13:857449. doi: https://doi.org/10.3389/fphar.2022.857449
33. Luo H, Wu H, Yu X, Zhang X, Lu Y, Fan J, et al. A review of the phytochemistry and pharmacological activities of Magnoliae officinalis cortex. J Ethnopharmacol. 2019;236:412–42. doi: https://doi.org/10.1016/j.jep.2019.02.041
34. Rauf A, Olatunde A, Imran M, Alhumaydhi FA, Aljohani ASM, Khan SA, et al. Honokiol: a review of its pharmacological potential and therapeutic insights. Phytomedicine. 2021;90:153647. doi: https://doi.org/10.1016/j.phymed.2021.153647
35. Zhu S, Liu F, Zhang R, Xiong Z, Zhang Q, Hao L, et al. Neuroprotective potency of neolignans in Magnolia officinalis cortex against brain disorders. Front Pharmacol. 2022 Jun 16;13:857449. doi: https://doi.org/10.3389/fphar.2022.857449
Year
Month